Moreover, researchers approved that as a most repeatedly in-activated tumor inhibitor gene in HNSCC, losing the level of p53 expression correlated to metastatic ability of HNSCC [165, 166]. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.